Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nicotine Gum Market by Type (2 mg/piece of gum dosage, 4 mg/piece of gum dosage), By Application (Withdrawal Clinics, Medical Practice, Individual Smokers, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nicotine Gum Market by Type (2 mg/piece of gum dosage, 4 mg/piece of gum dosage), By Application (Withdrawal Clinics, Medical Practice, Individual Smokers, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 153941 3300 Food & Beverages 377 232 Pages 4.9 (30)
                                          

Market Overview:


The global nicotine gum market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing number of smokers quitting smoking and the growing demand for smokeless tobacco products. In terms of type, the 2 mg/piece of gum dosage segment is expected to dominate the market during the forecast period owing to its high demand from withdrawal clinics and medical practices. However, with an increasing number of individual smokers using nicotine gums as an aid to quit smoking, the 4 mg/piece of gum dosage segment is projected to grow at a higher CAGR during the forecast period. Geographically, North America dominates the global nicotine gum market followed by Europe and Asia Pacific.


Global Nicotine Gum Industry Outlook


Product Definition:


Nicotine gum is a type of chewing gum that contains nicotine, a stimulant drug. It is used to help people stop smoking tobacco cigarettes. Nicotine gum helps reduce cravings for cigarettes and other tobacco products. It also helps relieve symptoms of nicotine withdrawal.


2 mg/piece of gum dosage:


2 mg/piece of gum is the dosage for nicotine chewing gums. These products are available in different flavors such as original, menthol, and fruit & nuts. The product is manufactured by many companies including Japan Tobacco Inc., British American Tobacco Plc., and Philip Morris International Inc.


4 mg/piece of gum dosage:


Nicotine Gums are available in different flavors such as original, menthol, and mint. The nicotine content in these products is 4 mg per piece. It is used for treating smoking addiction and to stop the desire to smoke. These products are also useful for people who are trying to quit smoking as it gives them a boost of nicotine which makes them want to quit smoking thus making it easier for them to do so.


Application Insights:


Based on application, the global nicotine gum market is segmented into individual smokers, medical practitioners and others. Withdrawal clinics held the largest share of the overall revenue in 2017 owing to high usage rates among individuals who have quit smoking tobacco and other forms of nicotine intake. The use of these products helps reduce cravings for cigarettes which may lead to a successful quitting attempt.


Medical practitioners are expected to be at higher risk of developing cardiovascular diseases due to constant exposure while treating patients with underlying heart conditions or during surgeries where they need nitroglycerine tablets for relief from angina pectoris attacks. This factor is anticipated to increase demand for nicotine gums in medical practices over the forecast period as it has been proven that these products help dilate blood vessels thereby lowering blood pressure levels significantly without any negative side effects as compared with conventional therapies used across various healthcare settings globally.


Regional Analysis:


North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high smoking prevalence and rising awareness about e-cigarettes among individuals as well as healthcare professionals. Asia Pacific is anticipated to witness lucrative growth over the coming years owing to increasing demand for nicotine replacement therapy products, such as gum, lozenges, patches & chewing gums, which are used for quitting smoking. Moreover, growing awareness regarding various substitutes of tobacco such as e-cigarettes will drive regional growth further.


The European market also held a significant share in terms of revenue and is expected to grow at a considerable rate over the forecast period owing tobuyer's confidence in these products coupled with favorable government regulations that support innovation pertaining tobaccorelated cessation aids & therapies along with raising public health concerns about secondhand smoke exposure caused by cigarettes resulting into restrictions on sales.


Growth Factors:


  • Increasing awareness about the harmful effects of smoking and the benefits of quitting smoking
  • Growing number of smokers looking for an alternative to cigarettes
  • Increased focus on public health and anti-smoking campaigns
  • Availability of nicotine gum in different flavors
  • Reduction in prices due to increased competition

Scope Of The Report

Report Attributes

Report Details

Report Title

Nicotine Gum Market Research Report

By Type

2 mg/piece of gum dosage, 4 mg/piece of gum dosage

By Application

Withdrawal Clinics, Medical Practice, Individual Smokers, Others

By Companies

Novartis, Perrigo Company, Pharmacia, Fertin Pharma, Revolymer, Johnson & Johnson, Alchem International, Cambrex Corporation, GlaxoSmithKline, Reynolds American, Dr. Reddy's Laboratories

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

232

Number of Tables & Figures

163

Customization Available

Yes, the report can be customized as per your need.


Global Nicotine Gum Market Report Segments:

The global Nicotine Gum market is segmented on the basis of:

Types

2 mg/piece of gum dosage, 4 mg/piece of gum dosage

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Withdrawal Clinics, Medical Practice, Individual Smokers, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Novartis
  2. Perrigo Company
  3. Pharmacia
  4. Fertin Pharma
  5. Revolymer
  6. Johnson & Johnson
  7. Alchem International
  8. Cambrex Corporation
  9. GlaxoSmithKline
  10. Reynolds American
  11. Dr. Reddy's Laboratories

Global Nicotine Gum Market Overview


Highlights of The Nicotine Gum Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 2 mg/piece of gum dosage
    2. 4 mg/piece of gum dosage
  1. By Application:

    1. Withdrawal Clinics
    2. Medical Practice
    3. Individual Smokers
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nicotine Gum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nicotine Gum Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Nicotine gum is a type of chewing gum that contains nicotine. Nicotine gum is used to help people quit smoking cigarettes.

Some of the major companies in the nicotine gum market are Novartis, Perrigo Company, Pharmacia, Fertin Pharma, Revolymer, Johnson & Johnson, Alchem International, Cambrex Corporation, GlaxoSmithKline, Reynolds American, Dr. Reddy's Laboratories.

The nicotine gum market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Nicotine Gum Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Nicotine Gum Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Nicotine Gum Market - Supply Chain
   4.5. Global Nicotine Gum Market Forecast
      4.5.1. Nicotine Gum Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Nicotine Gum Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Nicotine Gum Market Absolute $ Opportunity

5. Global Nicotine Gum Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Nicotine Gum Market Size and Volume Forecast by Type
      5.3.1. 2 mg/piece of gum dosage
      5.3.2. 4 mg/piece of gum dosage
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Nicotine Gum Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Nicotine Gum Market Size and Volume Forecast by Application
      6.3.1. Withdrawal Clinics
      6.3.2. Medical Practice
      6.3.3. Individual Smokers
      6.3.4. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Nicotine Gum Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Nicotine Gum Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Nicotine Gum Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Nicotine Gum Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Nicotine Gum Demand Share Forecast, 2019-2026

9. North America Nicotine Gum Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Nicotine Gum Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Nicotine Gum Market Size and Volume Forecast by Application
      9.4.1. Withdrawal Clinics
      9.4.2. Medical Practice
      9.4.3. Individual Smokers
      9.4.4. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Nicotine Gum Market Size and Volume Forecast by Type
      9.7.1. 2 mg/piece of gum dosage
      9.7.2. 4 mg/piece of gum dosage
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Nicotine Gum Demand Share Forecast, 2019-2026

10. Latin America Nicotine Gum Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Nicotine Gum Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Nicotine Gum Market Size and Volume Forecast by Application
      10.4.1. Withdrawal Clinics
      10.4.2. Medical Practice
      10.4.3. Individual Smokers
      10.4.4. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Nicotine Gum Market Size and Volume Forecast by Type
      10.7.1. 2 mg/piece of gum dosage
      10.7.2. 4 mg/piece of gum dosage
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Nicotine Gum Demand Share Forecast, 2019-2026

11. Europe Nicotine Gum Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Nicotine Gum Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Nicotine Gum Market Size and Volume Forecast by Application
      11.4.1. Withdrawal Clinics
      11.4.2. Medical Practice
      11.4.3. Individual Smokers
      11.4.4. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Nicotine Gum Market Size and Volume Forecast by Type
      11.7.1. 2 mg/piece of gum dosage
      11.7.2. 4 mg/piece of gum dosage
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Nicotine Gum Demand Share, 2019-2026

12. Asia Pacific Nicotine Gum Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Nicotine Gum Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Nicotine Gum Market Size and Volume Forecast by Application
      12.4.1. Withdrawal Clinics
      12.4.2. Medical Practice
      12.4.3. Individual Smokers
      12.4.4. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Nicotine Gum Market Size and Volume Forecast by Type
      12.7.1. 2 mg/piece of gum dosage
      12.7.2. 4 mg/piece of gum dosage
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Nicotine Gum Demand Share, 2019-2026

13. Middle East & Africa Nicotine Gum Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Nicotine Gum Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Nicotine Gum Market Size and Volume Forecast by Application
      13.4.1. Withdrawal Clinics
      13.4.2. Medical Practice
      13.4.3. Individual Smokers
      13.4.4. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Nicotine Gum Market Size and Volume Forecast by Type
      13.7.1. 2 mg/piece of gum dosage
      13.7.2. 4 mg/piece of gum dosage
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Nicotine Gum Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Nicotine Gum Market: Market Share Analysis
   14.2. Nicotine Gum Distributors and Customers
   14.3. Nicotine Gum Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Novartis
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Perrigo Company
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Pharmacia
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Fertin Pharma
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Revolymer
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Johnson & Johnson
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Alchem International
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Cambrex Corporation
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. GlaxoSmithKline
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Reynolds American
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Dr. Reddy's Laboratories
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us